Pharmaceutical business targeting the super-aged society
First written in FY2018. 12 of 13 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「To remain a pharmaceutical company needed in the accelerating “super-aged society”」
The company has reaffirmed its vision of remaining a pharmaceutical company needed in a super-aged society. - FY2022-Q3RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to position the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2022-Q2RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to position the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2022-Q1RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to position the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2021RestatedAnnual report
「The Group has identified the “super-aged society” as its business target and is promoting a pharmaceutical business adapted to the continuing acceleration of this trend, with 1 in 5 people expected to be aged 75 or older in 2025.」
The company has reaffirmed its positioning of the super-aged society as its business target. - FY2021-Q2RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to position the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2021-Q1RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to position the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2020-Q2RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to view the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2020-Q1RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to view the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2019RestatedAnnual report
「The Group has identified the “super-aged society” as its business target and is promoting a pharmaceutical business adapted to the continuing acceleration of this trend, with 1 in 5 people expected to be aged 75 or older in 2025.」
The company has reaffirmed its positioning of the super-aged society as its business target. - FY2019-Q3RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company continues to view the super-aged society in 2025 as the business environment for its generic pharmaceuticals business. - FY2019-Q2RestatedAnnual report
「In the generic pharmaceuticals industry, the “2025 problem,” under which 1 in 5 people will be aged 75 or older in 2025, is approaching」
The company has reiterated its view that the super-aged society in 2025 will be the premise for its business environment. - FY2018First statedAnnual report
「The Group has identified the “super-aged society” as its business target and is promoting a pharmaceutical business adapted to the continuing acceleration of this trend, with 1 in 5 people expected to be aged 75 or older in 2025.」
The company positions the super-aged society as a business opportunity and plans to promote its business against the backdrop of the projected population composition in 2025.